These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12409382)

  • 21. Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results.
    Naegele K; Lautenschlager I; Gosert R; Loginov R; Bir K; Helanterä I; Schaub S; Khanna N; Hirsch HH
    J Clin Virol; 2018 Jul; 104():39-47. PubMed ID: 29727833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of cytomegalovirus DNA in sera using the polymerase chain reaction: relationship with clinical diagnosis of cytomegalovirus infection after renal transplantation.
    Yamamoto T; Nakajima Y; Hironaka T; Hirai K; Nakamura Y
    Nephron; 1995; 70(1):100-3. PubMed ID: 7617086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the Biological Form of Human Cytomegalovirus DNA in the Plasma of Solid-Organ Transplant Recipients.
    Tong Y; Pang XL; Mabilangan C; Preiksaitis JK
    J Infect Dis; 2017 Apr; 215(7):1094-1101. PubMed ID: 28407149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.
    Hadaya K; Wunderli W; Deffernez C; Martin PY; Mentha G; Binet I; Perrin L; Kaiser L
    J Clin Microbiol; 2003 Aug; 41(8):3757-64. PubMed ID: 12904387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of human cytomegalovirus DNA in leukocytes by end-point titration and duplex polymerase chain reaction.
    Kulski JK
    J Virol Methods; 1994 Sep; 49(2):195-208. PubMed ID: 7822461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients.
    Salimnia H; Fairfax MR; Chandrasekar PH
    Transpl Infect Dis; 2014 Dec; 16(6):914-8. PubMed ID: 25412866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of cytomegalovirus using PCR in serum from renal transplant recipients.
    Cunningham R; Harris A; Frankton A; Irving W
    J Clin Pathol; 1995 Jun; 48(6):575-7. PubMed ID: 7665705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
    Bravo D; Clari MÁ; Costa E; Muñoz-Cobo B; Solano C; José Remigia M; Navarro D
    J Clin Microbiol; 2011 Aug; 49(8):2899-904. PubMed ID: 21697323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
    Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
    Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients.
    Taksinwarajarn T; Sobhonslidsuk A; Kantachuvesiri S; Thongprayoon C; Cheungpasitporn W; Bruminhent J;
    Transpl Infect Dis; 2021 Aug; 23(4):e13635. PubMed ID: 33982825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
    Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
    BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG).
    Hassan-Walker AF; Kidd IM; Sabin C; Sweny P; Griffiths PD; Emery VC
    J Med Virol; 1999 Jun; 58(2):182-7. PubMed ID: 10335868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test.
    Allice T; Enrietto M; Pittaluga F; Varetto S; Franchello A; Marchiaro G; Ghisetti V
    J Med Virol; 2006 Jul; 78(7):915-22. PubMed ID: 16721848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
    de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
    Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the loop-mediated isothermal amplification method for rapid detection of cytomegalovirus DNA.
    Suzuki R; Yoshikawa T; Ihira M; Enomoto Y; Inagaki S; Matsumoto K; Kato K; Kudo K; Kojima S; Asano Y
    J Virol Methods; 2006 Mar; 132(1-2):216-21. PubMed ID: 16289345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation.
    Mendez JC; Espy MJ; Smith TF; Wilson JA; Paya CV
    J Clin Microbiol; 1998 Feb; 36(2):526-30. PubMed ID: 9466770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.